Cymax Human MCP-1 ELISA Kit
- Known as:
- Cymax Human MCP-1 Enzyme-linked immunosorbent assay test Kit
- Catalog number:
- lf-ek0265
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- Abfrontier
- Gene target:
- Cymax Human MCP-1 ELISA Kit
Related genes to: Cymax Human MCP-1 ELISA Kit
- Gene:
- CCL2 NIH gene
- Name:
- C-C motif chemokine ligand 2
- Previous symbol:
- SCYA2
- Synonyms:
- MCP1, MCP-1, MCAF, SMC-CF, GDCF-2, HC11, MGC9434
- Chromosome:
- 17q12
- Locus Type:
- gene with protein product
- Date approved:
- 1990-07-05
- Date modifiied:
- 2016-10-05
- Gene:
- SLC25A14 NIH gene
- Name:
- solute carrier family 25 member 14
- Previous symbol:
- -
- Synonyms:
- BMCP1, UCP5
- Chromosome:
- Xq26.1
- Locus Type:
- gene with protein product
- Date approved:
- 1999-02-09
- Date modifiied:
- 2016-10-05
Related products to: Cymax Human MCP-1 ELISA Kit
Related articles to: Cymax Human MCP-1 ELISA Kit
- Resveratrol is a dietary polyphenol found in grapes, peanuts, and berries, with reported anti-inflammatory, immunomodulatory, barrier-protective, and microbiota-regulating properties. Functional dyspepsia (FD) is associated with duodenal immune dysregulation, epithelial barrier impairment, and microbial imbalance, suggesting an active mucosal microenvironment. This study therefore examined whether resveratrol could alleviate FD-like pathological changes. We also examined its links with epithelial homeostasis, gut microbiota, and chemokine- or cytokine-related ligand-receptor signaling. - Source: PubMed
Publication date: 2026/08/13
Lv YangGong WeiLi LongLi ZeliFu Jiarui NicoleZhi FachaoCai Shanshan - Glioblastoma, IDH-wildtype, is characterized by diffuse invasion, profound immunosuppression, treatment resistance, and near-inevitable recurrence. Although canonical genetic alterations establish malignant capacity, they do not fully explain how glioblastoma cells adapt to hypoxic, perivascular, invasive, immunosuppressive, metabolically constrained, and treatment-injured microenvironments. We examined how chemokine signaling contributes to these adaptive behaviors. - Source: PubMed
Publication date: 2026/08/26
Chojak RafalTurunen Jillyn RDrewes Noah BKoutah LaraFares JawadChen Rebecca XDu RuochenFaisal Umme HKazi Hasaan AKelley ClareMiska JasonHeimberger Amy BAhmed Atique ULesniak Maciej S - C-C motif chemokine ligand 2 (CCL2) interacts with cytokines, adipokines, miRNAs, and multiple synovial cell populations. Experimental studies indicate that these interactions can form a CCL2-associated inflammatory amplification network across cell types. In cellular and animal models, increased CCL2 is associated with monocyte recruitment, synovial fibroblast activation, osteoclast-related bone remodelling, and vascular responses. Therapeutic strategies targeting the CCL2-centered inflammatory network include antagonists of the CCL2/CCR2 axis, natural products, synthetic compounds, conventional antirheumatic drugs, and emerging delivery-based approaches. Notably, direct CCL2/CCR2 inhibition has shown biological activity in experimental models but has not produced consistent clinical benefit in established rheumatoid arthritis (RA). Although these findings do not establish CCL2 as a dominant causal driver of RA, human observational studies suggest that circulating CCL2 may complement established markers in preclinical RA risk assessment, disease activity and remission classification, estimation of treatment response, and evaluation of RA-related complications such as interstitial lung disease. Of note, no validated concentration cut-off or standardized assay currently supports its routine clinical use. This review examines the CCL2-related inflammatory network in RA and evaluates its cellular mechanisms, therapeutic implications, and potential clinical applications. - Source: PubMed
Publication date: 2026/08/14
Shi BowenBai KeLiu RenpingKuang NanzhenCai Wei - Dematiaceous fungi cause chronic, invasive cutaneous infections that are difficult to eradicate and frequently relapse despite antifungal therapy. Although host immunity is critical for controlling these infections, the temporal organization of immune responses and the underlying immunometabolic programs remain poorly defined. In particular, how macrophage dynamics and chemokine signaling shape antifungal immunity over time is largely unknown. - Source: PubMed
Publication date: 2026/08/05
Fu YongqiangLiu MengyingDong QiGuo XinyuLu JiejieWu WeiweiTakahashi HirokiZhang Ruijun - Nanobodies (Nbs) are new and promising tools for a variety of applications, including their use in medicine, although their functional activity and encounter with immune cells are still not well characterized. Our goal was to study the properties of Nbs coupled with the human IgG1 antibody Fc fragment (Nb-Fc), including their interaction with antigens, Fc receptors (FcRs), and professional phagocytes: macrophages. In our research, we employed a combination of two surface-sensitive methods: spectroscopic ellipsometry (SE) and quartz crystal microbalance with dissipation (QCM-D). It enabled the quantitative investigation of interaction kinetics between human FcγRI (CD64) and immune complexes (IC) formed by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein Wuhan variant (SCoV2-S) and specific Nb-Fc, as well as the optical and mechanical properties of the formed layers. Human THP-1 macrophage cell culture was used to analyze antigen and IC induced inflammatory response, antigen presentation-related processes, as well as chemokine CCL2/CCR2 and CCL5/CCR5 axes. Our investigated Nb-Fcs had a high affinity for SCoV2-S that was comparable to that of the natural human antibody CR3022. ICs formed by Nb-Fcs also interacted with FcRs in a similar way to CR3022. One of the investigated Nb-Fcs distinguished itself by its very high affinity and formed relatively the largest ICs. Interestingly, only ICs formed by the other Nb-Fcs influenced cellular response. We found increased cell surface expression of CD83. This molecule plays a regulatory role in antigen presentation and is involved in the resolution of inflammation following infection. In addition, we did not find any increase in other investigated markers in THP-1 macrophages, including the inflammatory response. Overall, our data demonstrate that Nb-Fcs can be applied in a similar manner to conventional human antibodies, considering their properties. - Source: PubMed
Publication date: 2026/08/19
Stančiauskaitė MiglėUsvaltas MantvydasMašalaitė KristinaLučiūnaitė AstaPlikusiene Ieva